Active-ingredient Dossier
Cyproterone Acetate
Active-ingredient Dossier for Cyproterone Acetate (antiandrogen). Australian brands, products, PBS listings, PBAC outcomes — compiled by arcimedes.
- Brand: CYPROTERONE SANDOZ
- Brand: ANDROCUR
- Brand: ANDROCUR-100
- Brand: Anterone
- Brand: APO-CYPROTERONE
- Brand: CYPROTERONE AN
- Therapeutic area: Reproductive Health
- Therapeutic area: Oncology
- Therapeutic area: Endocrinology
What is
Cyproterone Acetate Cyproterone acetate is an antiandrogen active ingredient. It is indicated across multiple therapeutic areas in Australia.
Australian brands containing
Cyproterone Acetate — CYPROTERONE SANDOZ — ANDROCUR — ANDROCUR-100 — Anterone — APO-CYPROTERONE — CYPROTERONE AN — CYROTONE — CYROTONE-100 — DIANE-35 — ESTELLE-35 — HEIDI-35 — JENE-35
Therapeutic areas
Cyproterone acetate is registered in oncology across 17 brands and in reproductive health across 7 brands.
Sponsor landscape
The ingredient is marketed by nine sponsors, including Strides Pharma Science, Arrotex Pharmaceuticals, Amdipharm Mercury, Cipla, GM Pharma, and Bayer.
PBS and regulatory activity
One brand containing cyproterone acetate has PBS-listed items, with the latest PBS schedule date of 1 May 2026.